Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Domain Associates is a venture capital firm founded in 1985 by Jim Blair and Brian Dovey, with offices in San Diego and Princeton. The firm specializes in biotechnology investments and has managed nine subsequent biotech venture capital funds. Currently, Domain Associates has $2.8 billion in assets under management (AUM) and has funded 194 companies in the biopharmaceutical, device, and diagnostic sectors.
Over its nearly four decades of operation, Domain Associates has established a strong track record, contributing to 90 initial public offerings (IPOs) and over 110 mergers and acquisitions (M&A). The companies it has supported have achieved a combined market capitalization of approximately $190 billion, showcasing the firm's significant impact in the life sciences sector.
Domain Associates primarily invests in the biotechnology sector, with a keen focus on therapeutics, diagnostics, and medical devices. The firm engages with companies at various stages of development, from Friends & Family rounds to Growth Equity and IPOs. This broad investment strategy allows Domain Associates to support innovative companies throughout their lifecycle, enhancing their potential for market success.
The firm looks for founders who demonstrate strong leadership and a clear vision for their companies. Domain Associates values strategic guidance and operational support, leveraging its extensive experience and network within the life sciences industry to facilitate growth and successful exits for its portfolio companies.
Domain Associates has invested in a diverse range of notable biopharmaceutical, device, and diagnostic companies. While specific names and descriptions of these portfolio companies are not provided, the firm has a history of successful investments that have led to significant market outcomes, including 90 IPOs and over 110 M&A events.
The firm’s portfolio reflects its commitment to advancing biotechnology and healthcare innovation, with a focus on companies that are poised to make substantial contributions to the industry. The extensive experience of Domain Associates in the life sciences sector positions it as a key player in supporting the growth of these companies.
James Blair, Partner - Co-founder of Domain Associates, James has extensive experience in the life sciences sector and has been instrumental in the firm's investment strategy.
Brian Dovey, Partner (In Memorium 2023) - Co-founder and a key figure in the firm's history, Brian contributed significantly to its growth and success.
Brian Halak, Partner - Brian brings a wealth of experience in biotechnology investments and has been involved in numerous successful funding rounds.
Kim Kamdar, Partner - Kim has a strong background in life sciences and plays a crucial role in identifying and supporting promising biotech companies.
Jesse Treu, Partner Emeritus - Jesse has a long history with Domain Associates and continues to provide valuable insights and guidance.
Nicole Vitullo, Partner - Nicole focuses on strategic investments in the biotechnology sector, leveraging her expertise to support portfolio companies.
Kathleen Schoemaker, Partner and CFO (In Memorium 2016) - Kathleen was instrumental in managing the firm's financial operations and strategy.
Lisa Kraeutler, Managing Director of Finance and Administration - Lisa oversees the firm's financial management and administrative functions.
Dennis Podlesak, Venture Partner - Dennis brings extensive experience in venture capital and supports the firm's investment activities.
Eckard Weber, Venture Partner - Eckard has a strong background in life sciences and contributes to the firm's investment strategy.
To pitch Domain Associates, founders should visit their website at domainvc.com. It is recommended to include a comprehensive pitch deck that outlines the business model, market opportunity, and financial projections. While specific response time expectations are not disclosed, founders should be prepared for a thorough evaluation process.
In 2023, Domain Associates mourned the loss of co-founder Brian Dovey, who played a pivotal role in shaping the firm since its inception in 1985. His contributions to the biotechnology investment landscape were significant.
Domain Associates continues to maintain a strong presence in the life sciences sector, with a portfolio that includes 194 companies and a history of 90 IPOs and over 110 M&A events, reflecting its ongoing commitment to supporting innovation in biotechnology.
What are Domain Associates' investment criteria?
Domain Associates invests primarily in the biotechnology sector, focusing on therapeutics, diagnostics, and medical devices. The firm engages with companies at various stages, from Friends & Family to IPO.
How can I apply or pitch to Domain Associates?
Founders can pitch to Domain Associates through their website at domainvc.com. It is advisable to include a detailed business plan and financial projections in the pitch deck.
What makes Domain Associates different from other venture capital firms?
Domain Associates has a long history in the biotechnology sector, having been founded in 1985. The firm has a proven track record of successful exits, including 90 IPOs and over 110 M&A events, which demonstrates its expertise and impact in the industry.
What is the geographic scope of Domain Associates' investments?
The firm primarily invests in the United States, focusing on the North American market while also considering global opportunities in biotechnology.
What is the typical check size for investments made by Domain Associates?
Domain Associates invests across various stages, and while specific check sizes are not disclosed, the firm typically engages in funding rounds from seed to growth equity, which can vary significantly based on the stage and needs of the company.
What kind of post-investment involvement does Domain Associates have?
Domain Associates provides strategic guidance and operational support to its portfolio companies, leveraging its extensive network in the life sciences sector to facilitate growth and successful exits.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.